Invesco Ltd.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 914208 Atlanta, GA

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,143,614,384

+$167,679,013 QoQ

Shares Held

2,561,057

+19.0% QoQ

Ownership

1.01%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 97.4721765271136.ToString("F0")% None 2.52782347288639.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. VRTX ranks #2 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,724,478	$1,332,400,669
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	2,561,057	$1,143,614,384
3	ARGX	Argenx SE	594,697	$434,277,482
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,291,726	$427,393,371
5	INCY	Incyte Corp	3,870,764	$364,316,298
6	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
7	INSM	INSMED Inc	1,988,968	$325,236,040
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,143,614,384	2,561,057	+19.0%	Shares	Defined	2026-05-12
2025-12-31	$975,935,371	2,152,672	+2.7%	Shares	Defined	2026-02-19
2025-09-30	$821,189,566	2,096,797	+5.7%	Shares	Defined	2025-11-13
2025-06-30	$883,297,273	1,984,046	+7.5%	Shares	Defined	2025-08-13
2025-03-31	$894,803,178	1,845,640	-2.8%	Shares	Defined	2025-05-12
2024-12-31	$764,508,626	1,898,457	-2.3%	Shares	Defined	2025-02-13
2024-09-30	$903,931,340	1,943,604	+7.8%	Shares	Defined	2024-11-12
2024-06-30	$844,981,218	1,802,742	-13.8%	Shares	Defined	2024-08-13
2024-03-31	$874,118,674	2,091,143	-6.7%	Shares	Defined	2024-05-14
2023-12-31	$912,290,908	2,242,107	+11.2%	Shares	Defined	2024-02-13
2023-09-30	$701,315,066	2,016,780	+3.5%	Shares	Sole	2023-11-13
2023-06-30	$685,988,358	1,949,329	+4.7%	Shares	Defined	2023-08-11
2023-03-31	$586,461,206	1,861,368	+14.6%	Shares	Defined	2023-05-12
2022-12-31	$469,238,321	1,624,899	+23.1%	Shares	Defined	2023-02-13
2022-09-30	$382,100,717	1,319,682	+17.5%	Shares	Defined	2022-11-14
2022-06-30	$316,392,113	1,122,794	-7.2%	Shares	Defined	2022-08-15
2022-03-31	$315,866,858	1,210,357	+7.9%	Shares	Defined	2022-05-16
2021-12-31	$246,425,893	1,122,158	-7.6%	Shares	Defined	2022-02-14
2021-09-30	$220,296,877	1,214,493	+4.2%	Shares	Sole	2021-11-15
2021-06-30	$235,117,309	1,166,083	+20.4%	Shares	Sole	2021-08-17
2021-03-31	$208,140,085	968,589	-11.8%	Shares	Defined	2021-05-17
2020-12-31	$259,482,643	1,097,921	-2.9%	Shares	Sole	2021-02-16
2020-09-30	$307,758,732	1,130,967	+1.0%	Shares	Sole	2020-11-16
2020-06-30	$325,062,713	1,119,709	-14.0%	Shares	Sole	2020-08-14
2020-03-31	$309,749,265	1,301,741	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.